Philippe Andreucci
CEO/Co-fondateur
I
Injectpower
Injectpower provides ultra‑miniature solid‑state microbatteries that can be wirelessly recharged via inductive coupling for implantable medical devices. The sub‑mm³ cells deliver high energy density, decade‑long cycle life, and hermetic biocompatibility, allowing continuous sensing or low‑power stimulation without surgical battery replacement. The batteries are manufactured with CMOS‑compatible semiconductor processes to meet medical‑device regulatory and supply‑chain requirements.
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Implantable medical devices often rely on bulky, finite‑life batteries that require surgical replacement or frequent external recharging, limiting their ability to provide continuous monitoring or long‑term electro‑stimulation. This constraint hampers the development of autonomous, data‑rich implants for chronic disease management and intra‑operative sensing.
Solution
Injectpower supplies ultra‑miniature, wirelessly rechargeable solid‑state microbatteries specifically engineered for smart implantable devices. The solid‑state chemistry eliminates liquid electrolytes, enhancing safety and longevity, while the compact form factor fits within millimeter‑scale implants. Wireless inductive charging delivers full recharge in a few minutes each week, enabling decades of operation without repeated surgeries. Batteries are fabricated using proven semiconductor processes with rigorous quality controls, ensuring a validated supply chain and high reliability. Integrated energy storage supports continuous in‑vivo measurement of biomarkers (e.g., intraocular pressure, intracranial fluid dynamics) and ultra‑low power electro‑stimulation, providing manufacturers a turnkey power solution that extends device functionality and data collection inside the body.
Target Audience
Primary customers are medical‑device manufacturers developing implantable sensors, drug‑delivery platforms, and neuro‑stimulation systems that require autonomous, long‑term power sources.
Features
- Micrometer‑scale solid‑state cell architecture delivering high energy density in a sub‑mm³ footprint
- Wireless inductive charging module achieving full recharge in ≤5 minutes weekly
- Decades‑long cycle life with negligible self‑discharge, suitable for chronic implant applications
- Semiconductor‑grade manufacturing using established CMOS‑compatible processes and strict statistical process control
- Certified biocompatibility and hermetic sealing for safe long‑term implantation
- Compatibility with a range of implant form factors, from pressure sensors to low‑current stimulators
- Integrated supply‑chain validation and traceability to meet medical device regulatory requirements